When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.Learn More
EU Divided on How to Use the AstraZeneca Covid Vaccine
Before it's here, it's on the Bloomberg Terminal.Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Key Statistics
P/E Ratio42.54
PEGY Ratio2.0221
Shares Outstanding1.31B
Price to Book Ratio8.7242
Price to Sales Ratio5.1178
1 Year Return-4.37%
30 Day Avg Volume2,231,042
EPS2.44
Dividend2.75%
Last Dividend Reported1.9
Earnings Announcement for Period Ending Q1/2021:04/30/2021
AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.Address
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB2 0AA
United Kingdom
